192 related articles for article (PubMed ID: 35367244)
1. Exercise regulation of hepatic lipid droplet metabolism.
Pino-de la Fuente F; Bórquez JC; Díaz-Castro F; Espinosa A; Chiong M; Troncoso R
Life Sci; 2022 Jun; 298():120522. PubMed ID: 35367244
[TBL] [Abstract][Full Text] [Related]
2. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD.
Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R
Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958
[TBL] [Abstract][Full Text] [Related]
3. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid droplet homeostasis and fatty liver disease.
Seebacher F; Zeigerer A; Kory N; Krahmer N
Semin Cell Dev Biol; 2020 Dec; 108():72-81. PubMed ID: 32444289
[TBL] [Abstract][Full Text] [Related]
5. A new perspective on NAFLD: Focusing on lipid droplets.
Scorletti E; Carr RM
J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
[TBL] [Abstract][Full Text] [Related]
6. Exercise regulates lipid droplet dynamics in normal and fatty liver.
la Fuente FP; Quezada L; Sepúlveda C; Monsalves-Alvarez M; Rodríguez JM; Sacristán C; Chiong M; Llanos M; Espinosa A; Troncoso R
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158519. PubMed ID: 31473346
[TBL] [Abstract][Full Text] [Related]
7. Lipid Droplet Contact Sites in Health and Disease.
Herker E; Vieyres G; Beller M; Krahmer N; Bohnert M
Trends Cell Biol; 2021 May; 31(5):345-358. PubMed ID: 33546922
[TBL] [Abstract][Full Text] [Related]
8. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease.
Li X; Yang Y; Sun Y; Ding S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542126
[TBL] [Abstract][Full Text] [Related]
9. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.
Zhang X; Wang Y; Liu P
Protein Cell; 2017 Jan; 8(1):4-13. PubMed ID: 27757845
[TBL] [Abstract][Full Text] [Related]
10. Lipid droplets and liver disease: from basic biology to clinical implications.
Gluchowski NL; Becuwe M; Walther TC; Farese RV
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):343-355. PubMed ID: 28428634
[TBL] [Abstract][Full Text] [Related]
11. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD.
Ma SY; Sun KS; Zhang M; Zhou X; Zheng XH; Tian SY; Liu YS; Chen L; Gao X; Ye J; Zhou XM; Wang JB; Han Y
Liver Int; 2020 Oct; 40(10):2427-2438. PubMed ID: 32339374
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism.
Ma X; Qian H; Chen A; Ni HM; Ding WX
Cells; 2021 Sep; 10(9):. PubMed ID: 34571924
[TBL] [Abstract][Full Text] [Related]
15. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
16. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
17. Impaired hepatic lipid metabolism and biomarkers in fatty liver disease.
Teixeira FS; Pimentel LL; Pintado ME; Rodríguez-Alcalá LM
Biochimie; 2023 Dec; 215():69-74. PubMed ID: 37769937
[TBL] [Abstract][Full Text] [Related]
18. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
Zhang Y; Chen Y
Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
20. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
Han YH; He XM; Jin MH; Sun HN; Kwon T
Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]